Neuromuscular Manifestations Clinical Trial
Official title:
Acute and Chronic Effects of Static and Dynamic Stretching on Flexibility and Neuromuscular and Functional Performance in Healthy Subjects: a Blinded and Randomized Clinical Trial
The purpose of this study is analyze the effects, acute and chronic, static and dynamic
stretching on flexibility and neuromuscular and functional performance in active, healthy
individuals.
Study hypothesis:
1. Static stretching program improves flexibility and reduces neuromuscular and functional
performance in active, healthy individuals.
2. Static stretching program improves flexibility and neuromuscular and functional
performance in active, healthy individuals.
Status | Completed |
Enrollment | 45 |
Est. completion date | December 2015 |
Est. primary completion date | December 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 18 Years to 28 Years |
Eligibility |
Inclusion Criteria: - (1) male; (2) were aged between 18 and 28 years old; (3) Body mass index (BMI) of 21 to 25 kg / m2, (4) not be participating in lower limb stretching programs; (5) be healthy, according to Physical Activity Readiness Questionnaire (PAR-Q) and perform physical activity (recreational, not competitive level) for at least 3 times a week, according to the International Physical Activity Questionnaire (IPAQ) (6) no history of injury or disease in the lower limbs in the last six months, without previous surgery in this segment; (7) lack of musculoskeletal, cardiorespiratory and neurological disorders that prevent the completion of the evaluation and treatment protocols; (8) is not under the effect of medicines that cause muscle relaxation or that inhibit muscle tonic action (9) has ROM limitation (degree of muscle shortening) of at least 15 ° of active extension of joelho21, the non-dominant leg (considering 180 the full extent with hip positioned at 90 ° of flexion). Exclusion Criteria: - (1) start stretching practice in daily activities during the study period; (2) not perform evaluative and intervention procedures; (3) absence of at least one of the sessions of stretching protocol; (4) appearance of lesions during the period in which the subject is inserted in the survey; (5) withdrawal in the study. Thus, it excluded eight volunteers, three per occurrence of injuries during the study period and five per withdrawal, concluding the study with a total of 45 subjects. |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Germanna de Medeiros Barbosa |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Range of Motion | Range of Motion measured by Universal Goniometer | Evaluation of range of motion after one month the application of stretching | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04931901 -
Paired Assessment of Two Electromyographic Neuromuscular Monitors: Stimpod NMX450X Versus Datex-Ohmeda E-NMT
|
N/A | |
Completed |
NCT03273114 -
Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain
|
N/A | |
Recruiting |
NCT06381284 -
Feasibility of Engaging and Capturing Undiagnosed Myasthenia Gravis Participants Through a Social Media Campaign Paired With a Self-moderated Assessment
|
||
Completed |
NCT03471923 -
Non-Motor Features of Cervical Dystonia (CD)
|
||
Completed |
NCT05738200 -
Nordic Hamstring Exercise After ACL Reconstruction Reconstruction
|
N/A | |
Completed |
NCT03211390 -
Using Telemedicine to Improve Spasticity Diagnosis Rates
|
||
Completed |
NCT03250988 -
Prevalence of Comorbid Spasticity and Urinary Incontinence in Residents of a Long-Term Care Facility
|
||
Completed |
NCT03209960 -
Validity and Inter-Rater Reliability of a Novel Bedside Referral Tool for Spasticity
|
||
Active, not recruiting |
NCT05156320 -
Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam
|
Phase 3 | |
Completed |
NCT03221439 -
Cognitive Functional Therapy for Chronic Low Back Pain
|
N/A | |
Completed |
NCT03921528 -
An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy
|
Phase 2 | |
Active, not recruiting |
NCT05626855 -
Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab-ONYX
|
Phase 3 | |
Recruiting |
NCT05810272 -
Impact of Postprandial 'Exercise Snacks' on Protein and Glucose Metabolism Following a Period of Step Reduction in Older Adults
|
N/A |